TrialClinical pharmacology and therapeutics2011

Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.

D K Hatsukami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.